Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES NATCO PHARMA DIVIS LABORATORIES/
NATCO PHARMA
 
P/E (TTM) x 30.0 26.1 114.8% View Chart
P/BV x 7.7 2.5 306.6% View Chart
Dividend Yield % 0.9 0.8 114.8%  

Financials

 DIVIS LABORATORIES   NATCO PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
NATCO PHARMA
Mar-22
DIVIS LABORATORIES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,4251,189 456.3%   
Low Rs3,562750 474.7%   
Sales per share (Unadj.) Rs337.5106.6 316.8%  
Earnings per share (Unadj.) Rs111.59.3 1,197.3%  
Cash flow per share (Unadj.) Rs123.317.1 719.6%  
Dividends per share (Unadj.) Rs30.004.50 666.7%  
Avg Dividend yield %0.70.5 143.9%  
Book value per share (Unadj.) Rs441.8233.4 189.3%  
Shares outstanding (eoy) m265.47182.52 145.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.39.1 146.3%   
Avg P/E ratio x40.3104.1 38.7%  
P/CF ratio (eoy) x36.556.6 64.4%  
Price / Book Value ratio x10.24.2 244.8%  
Dividend payout %26.948.3 55.7%   
Avg Mkt Cap Rs m1,192,890176,990 674.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9,4624,448 212.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,59819,448 460.7%  
Other income Rs m1,159990 117.1%   
Total revenues Rs m90,75720,438 444.1%   
Gross profit Rs m38,8112,635 1,472.9%  
Depreciation Rs m3,1151,426 218.5%   
Interest Rs m20177 11.3%   
Profit before tax Rs m36,8352,022 1,821.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,231322 2,245.5%   
Profit after tax Rs m29,6051,700 1,741.4%  
Gross profit margin %43.313.5 319.7%  
Effective tax rate %19.615.9 123.3%   
Net profit margin %33.08.7 378.0%  
BALANCE SHEET DATA
Current assets Rs m96,10424,972 384.8%   
Current liabilities Rs m24,5447,104 345.5%   
Net working cap to sales %79.991.9 86.9%  
Current ratio x3.93.5 111.4%  
Inventory Days Days970 12.4%  
Debtors Days Days987116 847.8%  
Net fixed assets Rs m50,08726,119 191.8%   
Share capital Rs m531365 145.5%   
"Free" reserves Rs m116,75142,237 276.4%   
Net worth Rs m117,28242,602 275.3%   
Long term debt Rs m00-   
Total assets Rs m146,19151,091 286.1%  
Interest coverage x1,842.812.4 14,832.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.4 161.0%   
Return on assets %20.33.7 551.6%  
Return on equity %25.24.0 632.6%  
Return on capital %31.45.2 608.8%  
Exports to sales %00-   
Imports to sales %19.720.0 98.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,6763,882 455.3%   
Fx inflow Rs m78,4458,881 883.3%   
Fx outflow Rs m17,9533,882 462.5%   
Net fx Rs m60,4924,999 1,210.1%   
CASH FLOW
From Operations Rs m19,118465 4,111.4%  
From Investments Rs m-21,949-53 41,413.6%  
From Financial Activity Rs m-5,324348 -1,530.0%  
Net Cashflow Rs m-8,156853 -956.1%  

Share Holding

Indian Promoters % 51.9 48.8 106.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 26.0 139.3%  
FIIs % 15.4 11.7 132.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 51.2 93.9%  
Shareholders   379,257 121,336 312.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Natco Pharma Share Price Performance

Period Divis Laboratories Natco Pharma S&P BSE HEALTHCARE
1-Day -1.05% 1.00% -0.10%
1-Month -10.49% -7.45% -1.99%
1-Year -29.17% -30.60% -5.62%
3-Year CAGR 23.76% -0.31% 20.96%
5-Year CAGR 26.80% -9.15% 11.47%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Natco Pharma the stake stands at 48.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Natco Pharma paid Rs 4.5, and its dividend payout ratio stood at 48.3%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.